Sophia Genetics SA (NAS:SOPH)
$ 4.73 -0.01 (-0.21%) Market Cap: 309.22 Mil Enterprise Value: 222.93 Mil PE Ratio: 0 PB Ratio: 2.34 GF Score: 40/100

Sophia Genetics SA Investor Day 2022 Transcript

Sep 20, 2022 / 05:30PM GMT
Release Date Price: $2.75 (+0.73%)
Jennifer Pottage
SOPHiA GENETICS SA - Head of IR

Hi, everyone. I'm Jennifer Pottage, Head of Investor Relations at SOPHiA GENETICS. I'm so pleased to welcome all of you today to our first ever Investor Day in New York City. And it's so great to have so many of you here with us in person. I'd also like to thank those of you who are joining us on webcast. We really appreciate your time and your attention.

I'm going to spend the next few minutes orienting you on what to expect this afternoon. We're going to start with some management presentations and then have a quick 15-minute break. After the break, we'll finish up the rest of the presentations and then go into a live Q&A session. And then after the Q&A session, we'd like to invite all of you on the terrace for a cocktail reception.

So I'm not going to read the entire cautionary notices slide, but please note, we will be making forward-looking statements for those of which actual results may differ materially than indicated. And so please read this slide and then also see our public filings.

So without further ado, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot